Main Findings

Overall, 74% of the European public interviewed agreed that there is a growing risk from counterfeit medicines. Agreement with this statement was highest in Germany (with 86% either agreeing or strongly agreeing), followed by Sweden (83%), Greece (82%) and Poland (72%).

In France and the United Kingdom, 61% and 55% respectively felt that there is a growing counterfeit medicines risk.